Coloplast A/S Market Cap ($15.65 Billion)
Market Cap & Net Worth: Coloplast A/S (COLO-B)
Coloplast A/S market cap. Coloplast A/S (CO:COLO-B) has a market capitalization of $15.65 Billion (Dkr100.01 Billion) as of November 1, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #1527 globally and #10 in its home market, demonstrating a 0.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Coloplast A/S's stock price Dkr482.30 by its total outstanding shares 207366796 (207.37 Million). Also see how efficiently does Coloplast A/S generate cash for how efficiently the company converts equity into cash flow.
Coloplast A/S Market Cap History (2015–2026)
Coloplast A/S market cap history from 2015 to 2026. Data shows growth from $14.78 Billion to $15.65 Billion (2.08% CAGR). Check COLO-B stock price for real-time trading data and today's change.
Index Memberships
Coloplast A/S is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Large 200 EUR Price
LCXP
|
$7.24 Trillion | 0.22% | #97 of 182 |
|
STOXX Europe Large 200 Net Return
LCXR
|
$7.24 Trillion | 0.22% | #97 of 182 |
Weight: Coloplast A/S's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Coloplast A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Coloplast A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Coloplast A/S (COLO-B) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.64x
Coloplast A/S's market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.88x
Coloplast A/S's market cap is 4.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.02 Billion | $14.68 Billion | $3.14 Billion | 0.89x | 4.14x |
| 2017 | $13.90 Billion | $15.53 Billion | $3.80 Billion | 0.89x | 3.66x |
| 2018 | $17.50 Billion | $16.45 Billion | $3.85 Billion | 1.06x | 4.55x |
| 2019 | $24.43 Billion | $17.94 Billion | $3.87 Billion | 1.36x | 6.31x |
| 2020 | $28.02 Billion | $18.54 Billion | $4.20 Billion | 1.51x | 6.68x |
| 2021 | $35.33 Billion | $19.43 Billion | $4.83 Billion | 1.82x | 7.32x |
| 2022 | $25.51 Billion | $22.58 Billion | $4.71 Billion | 1.13x | 5.42x |
| 2023 | $24.90 Billion | $24.50 Billion | $4.78 Billion | 1.02x | 5.21x |
| 2024 | $25.51 Billion | $27.03 Billion | $5.05 Billion | 0.94x | 5.05x |
| 2025 | $17.73 Billion | $27.87 Billion | $3.64 Billion | 0.64x | 4.88x |
Competitor Companies of COLO-B by Market Capitalization
Companies near Coloplast A/S in the global market cap rankings as of November 1, 2026. Also see Coloplast A/S (COLO-B) total assets for a full breakdown of the balance sheet.
Key companies related to Coloplast A/S by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.77 Billion USD ( €85.34 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #421 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #536 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $432.01 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.77 Billion | €184.30 |
| #421 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €87.50 |
| #536 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Coloplast A/S (2015–2026)
Market capitalization of Coloplast A/S from 2015 to today. Between 2015 and today, Coloplast A/S's market cap moved from $14.78 Billion to $ 15.65 Billion, with a yearly change of 2.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr15.65 Billion | -11.73% |
| 2025 | Dkr17.73 Billion | -30.50% |
| 2024 | Dkr25.51 Billion | +2.45% |
| 2023 | Dkr24.90 Billion | -2.40% |
| 2022 | Dkr25.51 Billion | -27.80% |
| 2021 | Dkr35.33 Billion | +26.10% |
| 2020 | Dkr28.02 Billion | +14.68% |
| 2019 | Dkr24.43 Billion | +39.66% |
| 2018 | Dkr17.50 Billion | +25.89% |
| 2017 | Dkr13.90 Billion | +6.74% |
| 2016 | Dkr13.02 Billion | -11.93% |
| 2015 | Dkr14.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Coloplast A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.65 Billion USD |
| MoneyControl | $15.65 Billion USD |
| MarketWatch | $15.65 Billion USD |
| marketcap.company | $15.65 Billion USD |
| Reuters | $15.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more